$6.18
-0.11-1.67%
Last update: Nov 6, 10:05 AM
Myriad Genetics Inc (MYGN) Stock Price, Quote, News & History
MYGNNASDAQ
Myriad Genetics (NASDAQ:MYGN) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been...
You can purchase shares of Myriad Genetics (NASDAQ:MYGN) through any online brokerage.
Other companies in Myriad Genetics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Myriad Genetics has a consensus price target of $9.86.
The stock price for Myriad Genetics (NASDAQ: MYGN) is $6.185 last updated November 6, 2026 at 10:05 AM EST.
There are no upcoming dividends for Myriad Genetics.
Myriad Genetics does not have any upcoming earnings scheduled.
There is no upcoming split for Myriad Genetics.
Myriad Genetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its...
